Shares of agilon health, inc. (NYSE:AGL – Get Rating) have earned a consensus rating of “Moderate Buy” from the nine research firms that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $29.14.
Several equities research analysts have commented on AGL shares. Royal Bank of Canada initiated coverage on agilon health in a research note on Wednesday, September 14th. They set an “outperform” rating and a $33.00 price target for the company. Truist Financial cut their target price on shares of agilon health from $33.00 to $29.00 and set a “buy” rating on the stock in a research note on Wednesday, September 7th. The Goldman Sachs Group lowered their price objective on agilon health from $38.00 to $34.00 and set a “buy” rating for the company in a report on Tuesday, November 15th. Wells Fargo & Company decreased their price target on shares of agilon health from $28.00 to $22.00 and set an “overweight” rating for the company in a report on Tuesday, November 15th. Finally, TheStreet cut agilon health from a “c-” rating to a “d+” rating in a research report on Thursday, August 18th.
agilon health Stock Performance
Shares of AGL stock opened at $17.72 on Tuesday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.48 and a current ratio of 2.48. The stock has a fifty day moving average price of $19.75 and a 200 day moving average price of $21.60. agilon health has a 1 year low of $14.36 and a 1 year high of $28.36. The stock has a market cap of $7.30 billion, a PE ratio of -68.15 and a beta of 0.78.
Insider Buying and Selling
In other agilon health news, insider Benjamin Shaker sold 29,548 shares of agilon health stock in a transaction that occurred on Thursday, October 20th. The shares were sold at an average price of $20.37, for a total value of $601,892.76. Following the transaction, the insider now owns 25,625 shares in the company, valued at $521,981.25. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other news, insider Benjamin Kornitzer sold 5,396 shares of agilon health stock in a transaction that occurred on Monday, October 17th. The shares were sold at an average price of $21.79, for a total value of $117,578.84. Following the transaction, the insider now directly owns 10,426 shares of the company’s stock, valued at $227,182.54. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Benjamin Shaker sold 29,548 shares of the company’s stock in a transaction that occurred on Thursday, October 20th. The shares were sold at an average price of $20.37, for a total transaction of $601,892.76. Following the completion of the sale, the insider now owns 25,625 shares of the company’s stock, valued at approximately $521,981.25. The disclosure for this sale can be found here. Insiders have sold 67,320 shares of company stock worth $1,468,302 in the last ninety days. 3.30% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the business. FMR LLC boosted its stake in shares of agilon health by 14.9% during the 2nd quarter. FMR LLC now owns 34,862,287 shares of the company’s stock valued at $761,043,000 after buying an additional 4,512,008 shares during the period. Vanguard Group Inc. raised its stake in shares of agilon health by 14.7% during the 3rd quarter. Vanguard Group Inc. now owns 18,770,560 shares of the company’s stock worth $439,605,000 after purchasing an additional 2,407,116 shares in the last quarter. Durable Capital Partners LP lifted its holdings in shares of agilon health by 34.0% during the 3rd quarter. Durable Capital Partners LP now owns 9,429,055 shares of the company’s stock valued at $220,828,000 after buying an additional 2,392,134 shares during the last quarter. Wellington Management Group LLP grew its stake in shares of agilon health by 11.0% in the 1st quarter. Wellington Management Group LLP now owns 18,578,035 shares of the company’s stock valued at $470,953,000 after buying an additional 1,834,890 shares in the last quarter. Finally, Capital Research Global Investors increased its holdings in agilon health by 18.4% in the first quarter. Capital Research Global Investors now owns 9,867,875 shares of the company’s stock worth $250,151,000 after buying an additional 1,536,506 shares during the last quarter.
agilon health Company Profile
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider agilon health, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and agilon health wasn’t on the list.
While agilon health currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
Source: news.google.com
